The panel on Reimagining healthcare in a globalized world – Post COVID was a deep insighted discussion with well-known scientists and thought leaders Dr Krishna Ella, Chairman & Managing Director, Bharat Biotech International Limited (BBIL)and Dr Sanjay Singh, Chief Executive Officer, Gennova Biopharmaceuticals with Prof Dr Rajib Dasgupta, Chairperson, Centre …
Read More »covaxin: Bharat Biotech ramps up Covaxin production capacity to 700 mn doses per annum
To support vaccination campaigns in India and across the globe, Bharat Biotech has ramped up the manufacturing capacity of its COVID-19 vaccine, Covaxin, to 700 million doses per annum, the vaccine maker said on Tuesday. Manufacturing scale up has been carried out in a stepwise manner across multiple facilities at …
Read More »